N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide

C10H13BrN4OS — CID 174089321

IUPACN-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide
SMILESCC(=O)N[C@@H]1[C@H]2CC[C@H]1N(c1nnc(Br)s1)C2
InChIInChI=1S/C10H13BrN4OS/c1-5(16)12-8-6-2-3-7(8)15(4-6)10-14-13-9(11)17-10/h6-8H,2-4H2,1H3,(H,12,16)/t6-,7+,8+/m0/s1
InChIKeyUAIQRVNHOWXXCF-XLPZGREQSA-N
MW317.21 g/mol
LogP1.40
Rot. Bonds2

About N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide

N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide (PubChem CID 174089321) has the molecular formula C10H13BrN4OS and a molecular weight of 317.21 g/mol. Its IUPAC name is N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide.

Molecular Properties

Compound NameN-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide
PubChem CID174089321
Molecular FormulaC10H13BrN4OS
Molecular Weight317.21 g/mol
Exact Mass316.00
IUPAC NameN-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide
SMILESCC(=O)N[C@@H]1[C@H]2CC[C@H]1N(c1nnc(Br)s1)C2
InChIInChI=1S/C10H13BrN4OS/c1-5(16)12-8-6-2-3-7(8)15(4-6)10-14-13-9(11)17-10/h6-8H,2-4H2,1H3,(H,12,16)/t6-,7+,8+/m0/s1
InChIKeyUAIQRVNHOWXXCF-XLPZGREQSA-N
XLogP1.40
TPSA58.12 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms17
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500317.21
LogP ≤ 51.40
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide?
The IUPAC name of N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide (CID 174089321) is N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide.
What is the SMILES notation for N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide?
The canonical SMILES for N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide is CC(=O)N[C@@H]1[C@H]2CC[C@H]1N(c1nnc(Br)s1)C2.
What is the InChIKey of N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide?
The InChIKey is UAIQRVNHOWXXCF-XLPZGREQSA-N. The full InChI is InChI=1S/C10H13BrN4OS/c1-5(16)12-8-6-2-3-7(8)15(4-6)10-14-13-9(11)17-10/h6-8H,2-4H2,1H3,(H,12,16)/t6-,7+,8+/m0/s1.
What are the key properties of N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide?
N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide has a molecular weight of 317.21 g/mol, XLogP of 1.40, 2 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R,4S,7R)-2-(5-bromo-1,3,4-thiadiazol-2-yl)-2-azabicyclo[2.2.1]heptan-7-yl]acetamide is sourced from PubChem (CID 174089321), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).